PATENT-PENDING ADJUDICATION TECHNOLOGY
Designed to deliver your drug at the best price, every time.
With Rexi, you and your members have the data and tools you need at your fingertips.
Rexi stands out from the crowd. While most PBMs rely on systems built decades ago, Rescription has taken a novel approach leveraging new types of point-of-sale best price adjudication and cutting-edge AI to develop a truly novel solution.
By combining market-leading adjudication technology with innovative new programs to save plan sponsors and members on prescription drugs, Rexi delivers one-of-a-kind claims adjudication built around you and your needs.
Claim Adjudication Engine
Rescription values our collaborations with plan sponsors and hospital systems, which is why we built into Rexi user-friendly tools to share data and make our joint operations seamless.
Care Enablement Platform
Members deserve real-time access to their prescription data, including personalized drug pricing lookup at over 60,000 pharmacies nationwide. myRescription is built on top of Rexi so data your members see is always up-to-date.
Rescription has no incentive for you or your members to spend more on any drugs, so our claims adjudication logic compares multiple prices for each drug at over 64,000 pharmacies nationwide to make sure you're getting the lowest price available. We leverage guaranteed published NADAC pricing, pharmacy cash pay pricing, and we're constantly on the lookout for new partners and price models that will drive your costs down.
The Rescription Saver Program offers an innovative pathway to significantly reduce costs on the most expensive prescription drugs. Using Rexi, our patent-pending technology, and partnerships with health systems, we apply savings to high-cost drugs at the point-of-sale.